FDA NDC Directory · JSON-LD · Markdown

PEMAZYRE

NDC 50881-028 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namepemigatinib
Labeler / ManufacturerIncyte Corporation
Marketing categoryNew Drug Application (innovator) · App NDA213736
Dosage form / routeTABLET · ORAL
Active ingredientsPEMIGATINIB (13.5 mg/1)
Marketing started20200417
Package count1

External sources

Source: openFDA. Public-domain (CC0).